Patient decisions for disclosure of secondary findings among the first 200 individuals undergoing clinical diagnostic exome sequencing.
about
Incidental Findings with Genomic Testing: Implications for Genetic Counseling PracticeThe Human Genome Project, and recent advances in personalized genomicsStakeholder views on secondary findings in whole-genome and whole-exome sequencing: a systematic review of quantitative and qualitative studies.A new approach to assessing affect and the emotional implications of personal genomic testing for common disease riskReporting Incidental Findings in Genomic Scale Clinical Sequencing-A Clinical Laboratory Perspective: A Report of the Association for Molecular Pathology.Management of Incidental Findings in the Era of Next-generation SequencingResearch participants in NGS studies want to know about incidental findingsEthical Considerations for the Return of Incidental Findings in Ophthalmic Genomic Research.Preferences for return of incidental findings from genome sequencing among women diagnosed with breast cancer at a young age.Research participant interest in primary, secondary, and incidental genomic findings.A Systematic Review of the Management of Incidental Findings in Genomic Research.Integrating massively parallel sequencing into diagnostic workflows and managing the annotation and clinical interpretation challenge.Next generation sequencing and the future of genetic diagnosis.Defining and managing incidental findings in genetic and genomic practice.CAGI4 SickKids clinical genomes challenge: A pipeline for identifying pathogenic variants.Genome-Wide Sequencing for Prenatal Detection of Fetal Single-Gene Disorders.The long tail and rare disease research: the impact of next-generation sequencing for rare Mendelian disorders.Whole-exome sequencing in pediatrics: parents' considerations toward return of unsolicited findings for their child.Unsolicited findings of next-generation sequencing for tumor analysis within a Dutch consortium: clinical daily practice reconsidered.Choices of incidental findings of individuals undergoing genome wide sequencing, a single center's experience.Choices for return of primary and secondary genomic research results of 790 members of families with Mendelian disease.Revealing the results of whole-genome sequencing and whole-exome sequencing in research and clinical investigations: some ethical issues.Successful Application of Whole Genome Sequencing in a Medical Genetics Clinic.Genomic medicine for kidney disease.The who, what, and why of research participants' intentions to request a broad range of secondary findings in a diagnostic genomic sequencing study.Cancer patients' intentions towards receiving unsolicited genetic information obtained using next-generation sequencing.Great expectations: patient perspectives and anticipated utility of non-diagnostic genomic-sequencing results.The Psychosocial Impact of Carrying a Debated Variant in the GLA Gene.Anticipated responses of early adopter genetic specialists and nongenetic specialists to unsolicited genomic secondary findings.Patient Decisions to Receive Secondary Pharmacogenomic Findings and Development of a Multidisciplinary Practice Model to Integrate Results Into Patient Care.Principles of Genetic Counseling in the Era of Next-Generation Sequencing.Why Patients Decline Genomic Sequencing Studies: Experiences from the CSER Consortium.Pediatric Whole Exome Sequencing: an Assessment of Parents' Perceived and Actual Understanding.Informed Consent and the Disclosure of Clinical Results to Research Participants.Ethical Issues in Contemporary Clinical GeneticsPatients and families generally welcome secondary genomic findings: support for return of incidental findings may encourage shift toward predictive genetic testingGenomic sequencing identifies secondary findings in a cohort of parent study participants
P2860
Q26777211-FF762486-CBB6-4999-ADB4-011CCF5ABC4DQ26861372-EA9DC878-E96B-42CF-8D34-DB18BE4D0D16Q33737044-E3E359B5-58F7-4408-B0D1-F64EF6E4139EQ35143295-A5CC9500-C105-46E7-BA60-49691A489445Q35561832-1E5B3D25-8802-41DC-89FF-086AA65D620EQ35697689-57B20D3D-CFC8-4222-AAC5-C6221B686C08Q36116704-69CAFBB7-9E54-4B87-9829-F24F5F156D87Q36590467-72C5D13C-00C3-4351-9BD3-348826EDB4E7Q36868046-EF598131-1B0E-4CC6-B799-84E48BF14962Q37358417-8FA4CDB8-D65B-42D6-B867-D3F862A4FA01Q37725757-DB729F53-A2E6-45EE-A90B-CB94E6FE97CEQ38186626-7940D563-64ED-42FA-96E8-22AA37E0F6C9Q38232771-61F8F350-A0D6-4292-A032-2A52FE489B6EQ38250263-630F034D-91FA-4ADF-9432-FF03BAD0E50AQ38433489-60B24A61-D7D5-416A-95C1-C089C90FCE3DQ38562550-F4FEABFF-FD7C-49E7-922B-8ED6BAAB3A99Q38586076-BC2E7993-0D00-416A-BE98-45DEEBCE81F1Q38837649-078AD65A-065B-4A1D-9F0F-CC0326B93D2BQ38882097-16F8561F-9CE7-4CBC-8D78-42ED46FCDC63Q38890297-A7EF220C-17B6-4876-AB83-5E04DF4FFCB6Q38921250-C735F788-7984-492E-8853-98205E41BC59Q45183763-B0BD3648-293E-4E37-9F87-E61462BDA2E0Q46225649-BCBB483E-B3C6-4868-9196-383BEFA0A462Q47200436-9DC29313-2D3E-46DB-B835-4B70A5E20E2AQ47278797-50DE94C5-772D-4030-9D8D-F70C37D806D3Q47552732-0A6BFA56-D5E6-42B4-B09B-CD7AD324B4FFQ48214056-70786E7B-694D-410F-82F6-29A1F579CF0EQ48255162-15DAA72E-D48E-4CE6-A104-C08040327E26Q49498072-1E9AC87C-CFB2-4453-820E-405BBB71F3C5Q49951884-E915420F-E60E-4FB0-AD4B-7197518BF47CQ52333760-474D11F0-C137-4E40-9028-1404498AA97EQ52677797-960E7BEE-6278-4B55-A08D-A3665D34DD53Q52775606-B5AF7205-D798-419A-9504-1D6B46A14994Q54455428-996EB434-75CF-4200-8E35-EFD7E7E01100Q57131279-33E1C3DD-D2B6-46E1-99CC-30AA63447282Q57642960-CBED4055-89EF-4CF7-8F2E-88132D639300Q57643342-9C2076C3-C6A7-4747-98A8-93C9F2810F8C
P2860
Patient decisions for disclosure of secondary findings among the first 200 individuals undergoing clinical diagnostic exome sequencing.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Patient decisions for disclosu ...... l diagnostic exome sequencing.
@ast
Patient decisions for disclosu ...... l diagnostic exome sequencing.
@en
type
label
Patient decisions for disclosu ...... l diagnostic exome sequencing.
@ast
Patient decisions for disclosu ...... l diagnostic exome sequencing.
@en
prefLabel
Patient decisions for disclosu ...... l diagnostic exome sequencing.
@ast
Patient decisions for disclosu ...... l diagnostic exome sequencing.
@en
P2093
P2860
P356
P1433
P1476
Patient decisions for disclosu ...... al diagnostic exome sequencing
@en
P2093
Elizabeth C Chao
Erika Palmaer
Layla Shahmirzadi
Melissa C Parra
P2860
P2888
P304
P356
10.1038/GIM.2013.153
P407
P577
2013-10-10T00:00:00Z